Instylla First-In-Human Clinical Trial Published Results Demon...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEDFORD, Mass., March 15, 2022 /PRNewswire-AsiaNet/ -- --Prospective multicenter study evaluated the safety and efficacy of a PEG-based liquid embolic in treating hypervascular tumorsInstylla, Inc. ( https://instylla.com ), a privately held company developing next-generation liquid embolics for pe...
Authors: LATEST ASIANET NEWS RELEASES